Fabian Fröhlich

Has grant

Group Leader

The Francis Crick Institute
Country flagUnited Kingdom

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Close

Unraveling melanoma adaptive resistance through kinetic and statistical modeling

Open Date: 2019-06-01

Close Date: 2022-03-01

Grant: Close

GSC 1006:  Graduate School of Quantitative Biosciences Munich (QBM)

Open Date: 2012-01-01

Close Date:

Articles (8)

Year:

2026

Highly multiplexed imaging assays allow simultaneous quantification of multiple protein and phosphorylation markers, providing a static snapshots of cell types and states. Pseudo-time techniques can transform these static snapshots of unsynchronized cells into dynamic trajectories, enabling the study of dynamic processes such as development trajectories and the cell cycle. Such ordering also enables training of mathematical models on these data, but technical challenges have hitherto made it difficult to integrate multiple experimental conditions, limiting the predictive power and insights these models can generate. In this work, we propose data processing and model training approaches for integrating multiplexed, multi-condition immunofluorescence data with mathematical modelling. We devise training strategies for mathematical models that are applicable to datasets where cells exhibit oscillatory as well as arrested dynamics and use them to train a cell cycle model on a dataset of MCF-10A mammary epithelial cells exposed to cell-cycle arresting small molecules. We validate the model by investigating predicted growth factor sensitivities and responses to inhibitors of cells at different initial conditions. We anticipate that our framework will generalise to other highly multiplexed measurement techniques such as mass-cytometry, rendering larger bodies of data accessible to dynamic modelling and paving the way to deeper biological insights.

Year:

2025

The PI3K/AKT/mTOR pathway is central to cell metabolism and growth. However, pharmacological inhibition of the pathway is not uniformly effective across cancer types, or even within a single cancer model. In this study, we leverage oblique plane microscopy of triple negative breast cancer organoids, as well as lineage tracing to uncover a source of heterogeneity. Non-genetic resistance to AKT inhibition is associated with basal cell features of normal breast epithelium and the master transcription factor of basal cell state, ΔNp63α, is sufficient to confer resistance. Cells can transition between states within four weeks and therefore, AKT inhibition only delays tumour growth, with tumours rich in KRT14+ cells resulting. Thus, under selection, triple negative breast cancer exploits a repertoire of cell states inherent to the breast.

Year:

2025

Highly multiplexed imaging assays allow simultaneous quantification of multiple protein and phosphorylation markers, providing a static snapshots of cell types and states. Pseudo-time techniques can transform these static snapshots of unsynchronized cells into dynamic trajectories, enabling the study of dynamic processes such as development trajectories and the cell cycle. Such ordering also enables training of mathematical models on these data, but technical challenges have hitherto made it difficult to integrate multiple experimental conditions, limiting the predictive power and insights these models can generate. In this work, we propose data processing and model training approaches for integrating multiplexed, multi-condition immunofluorescence data with mathematical modelling. We devise training strategies that are applicable to datasets where cells exhibit oscillatory as well as arrested dynamics and use them to train a cell cycle model on a dataset of MCF-10A mammary epithelial exposed to cell-cycle arresting small molecules. We validate the model by investigating predicted growth factor sensitivities and responses to inhibitors of cells at different initial conditions. We anticipate that our framework will generalise to other highly multiplexed measurement techniques such as mass-cytometry, rendering larger bodies of data accessible to dynamic modelling and paving the way to deeper biological insights. Author Summary Advanced imaging techniques allow us to see detailed pictures of different proteins and cell changes. By using computational algorithms, we turn these static pictures into dynamic sequences to understand processes like the cell cycle better. However, combining data from different experiments is difficult and limits how well our models can predict outcomes. This study introduces new ways to process data and train models to handle complex data from various conditions. The approach is tested by using data from untreated and treated cells to create a model of the cell cycle. This model was then checked for accuracy by seeing how well it could predict how cells respond to growth factors and drugs from different starting points. In the future, this method could be used with other data types, allowing for more detailed and accurate models of cellular behavior.

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Collaborators (14)

Andrea Serio

Group Leader (Seconded)

King’s College London

UNITED KINGDOM
View details

Rebecca Lee

The University of Manchester

UNITED KINGDOM
View details

Morag Park

McGill University

CANADA
View details

Svenja Kemmer

University of Freiburg

GERMANY
View details

Chengzhe Tian

Junior Professor

University of Stuttgart

GERMANY
View details

James MacRae

Head of metabolomics

The Francis Crick Institute

UNITED KINGDOM
View details

Matthias König

Professor of Metabolic Inflammation and Carcinogenesis of the Liver

University of Lübeck

GERMANY
View details

Chris Dunsby

-

UNITED KINGDOM
View details

Peter Sorger

Otto Krayer Professor of Systems Pharmacology

Harvard Medical School

UNITED STATES
View details

James Briscoe

The Francis Crick Institute

UNITED KINGDOM
View details

Erik Sahai

The Francis Crick Institute

UNITED KINGDOM
View details

Rachael Natrajan

Team Leader

Institute of Cancer Research

UNITED KINGDOM
View details

Frank Bergmann

Ruprecht Karls Universität Heidelberg

GERMANY
View details

Jeremy Muhlich

Massachusetts Institute of Technology

UNITED STATES
View details